Who Owns Lipocine Stock?
NASDAQ: LPCNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 1.86 -3.63%
Ownership breakdown
- Held by institutions
- 36.19%
- Held by insiders
- 4.96%
- Institutional holders
- 38
- Institutions 36.2%
- Insiders 5.0%
- Public and other 58.8%
Who owns Lipocine stock?
Institutional investors own about 36.2% of Lipocine's shares, spread across 38 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 4.96% of LPCN.
The largest institutional holders are Squadron Capital Management LLC (9.83%), Ikarian Capital, LLC (6.17%) and Eversept Partners, LP (3.58%). Together, the top 10 institutions control 30.4% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their LPCN positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LPCN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Squadron Capital Management LLC | 810.00K | 9.83% | +80.0% |
| Ikarian Capital, LLC | 508.56K | 6.17% | 0.0% |
| Eversept Partners, LP | 294.99K | 3.58% | 0.0% |
| Vanguard Capital Management LLC | 230.82K | 2.80% | +15.0% |
| Acadian Asset Management. LLC | 170.42K | 2.07% | +100.0% |
| Boothbay Fund Management, LLC | 140.49K | 1.70% | 0.0% |
| Jane Street Group, LLC | 95.23K | 1.16% | +375.5% |
| Blackrock Inc. | 89.27K | 1.08% | 0.0% |
| Two Sigma Investments, LP | 84.89K | 1.03% | +151.5% |
| Citadel Advisors Llc | 81.22K | 0.99% | +179.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LPCN
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 142.77K | 1.73% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 57.90K | 0.70% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 43.75K | 0.53% |
| TR PRICE-Price (T.Rowe) U.S. Equities Trust | 12.27K | 0.15% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 8.69K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 8.29K | 0.10% |
| TIFF INVESTMENT PROGRAM-TIFF Multi-Asset Fund | 6.20K | 0.08% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Sustainability Core 1 PORT. | 6.18K | 0.07% |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 6.04K | 0.07% |
| Dimensional ETF Trust-Dimensional US Core Equity 1 ETF | 5.12K | 0.06% |
Frequently asked questions
Who is the largest shareholder of Lipocine?
Squadron Capital Management LLC is the largest institutional shareholder of LPCN, owning 9.83% of shares outstanding (810.00K shares) as of its latest 13F filing.
What percentage of Lipocine is owned by institutions?
Institutions own about 36.2% of LPCN shares and 38.1% of the public float.
How much of Lipocine do insiders own?
Insiders, such as officers and directors, own about 4.96% of LPCN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.